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ABSTRACT
Introduction: The HpOne test is a new f ive-
minute rapid urease test developed for the 
rapid detection of Helicobacter pylori infection 
during gastroscopy. However, evidence in 
the literature supporting its use clinically 
is scarce. The most commonly used rapid 
urease test remains the Campylobacter -
like organism (CLO) test , which generates 
accurate readings only after 24 hours. The aim 
of this study was to evaluate the efficacy of the 
HpOne test in our local population.
Methods : From August 2007 to May 2008, 
consecutive patients undergoing gastroscopy 
for var ious indicat ions were recruited 
into this prospective study. Patients who 
were pregnant, lactating, on proton pump 
inhibitors, antibiotics, immunosuppressants 
or had previous gastric surgery were excluded. 
During gastroscopy, s ix gastric mucosal 
biopsies were taken; three from the body and 
three from the antrum. One body and one 
antral biopsy were used for each of the HpOne 
test, CLO test and histology. Results of the 
HpOne and CLO tests were then compared 
against the gold standard of histology.
Results : Of the 149 patients recruited, 82 
(55 percent) were men and 67 (45 percent) 
were women. The prevalence of Helicobacter 
pylori infection was 38.9 percent (n is 58) . 
The sensitivity and specif icity of the HpOne 
test were 65.5 percent and 85.7 percent , 
respectively, while those for the CLO test were 
63.8 percent and 84.6 percent, respectively.
 Conclusion: The HpOne test is as eff icacious 
as the CLO test, with the added advantage 
of yielding results faster. It is thus a superior 
alternative and should be considered for 
clinical use.
Keywords : CLO test, diagnosis, Helicobacter 
pylori, HpOne, rapid urease test
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INTRODUCTION
Helicobacter pylori (H. pylori) is a micro-aerophilic, 
Gram-negative spirochete that was first isolated by 
Warren and Marshall almost three decades ago. 
Since then, it has been shown to be a widespread and 
infectious bacterium, affecting approximately 50% 
of the world’s population(1) and more than one-third of 
Singaporeans.(2) Significant clinical outcomes following 
the infection include(1) chronic gastritis, peptic ulcers, 
mucosa-associated lymphoid tissue lymphomas and most 
importantly, gastric adenocarcinoma.
 The most recent recommendation by the American 
College of Gastroenterologists(3) states that if endoscopy is 
required owing to the patient’s presentation, biopsy-based 
endoscopic tests are the most appropriate tool to diagnose 
H. pylori infection. The most extensively studied and 
widely used of these tests remains the Campylobacter-
like organism (CLO) test® (Delta West, Bentley, WA, 
Australia), an agar gel test. However, evidence has shown 
that the results of the test are best read only after 24 
hours.(4)
 The HpOne test® (GI Supply, Camp Hill, PA, USA) 
may potentially be a superior alternative, as its highest 
concordance with the gold standard of histology has 
been reported to be maximal at one hour. However, 
evidence supporting its use in clinical practice has been 
scarce, with only a small study(5) being reported in the 
literature thus far. The authors of this paper thus aimed 
to validate the efficacy of the HpOne test as compared 
to the gold standard of histology, to determine its 
sensitivity and specificity in the detection of H. pylori 
infection, as well as to explore the possibility of its use 
in our local setting.
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METHODS
From August 2007 to May 2008, consecutive patients 
undergoing gastroscopy for various indications at the 
Endoscopy Unit of Alexandra Hospital, Singapore were 
recruited for this study. Patients who had been taking 
proton pump inhibitors or antibiotics one month prior to 
the endoscopy session, on chronic immunosuppressant 
therapy or had previous gastric surgery, as well as 
pregnant or lactating women, were excluded. Written 
informed consent was obtained from all participants 
before enrolment into the study. Approval for the 
study was obtained from the Domain Specific Review 
Board (domain D) and funding provided by the NMRC 
Enabling Grant, thus ensuring that no extra cost was 
borne by the patients.
 Each patient fasted for a minimum of six hours. 
Thereafter, gastroscopy was performed using an 
Olympus gastroscope (Olympus Medical Systems 
Corp, Tokyo, Japan). Six gastric mucosal biopsies were 
obtained from each patient; three from the antrum and 
three from the gastric body. Two biopsy specimens (one 
each from the antrum and gastric body) were each used 
for the HpOne test, CLO test and histology (Fig. 1). A 
co-investigator interpreted the results of the HpOne and 
CLO tests at 30 minutes, 60 minutes and 24 hours after 
commencement of the tests. The tests were considered 
positive when either specimen recorded a positive result. 
An experienced senior pathologist evaluated the biopsy 
specimens and provided the histological findings.
 Statistical analysis was performed using the 
Statistical Package for the Social Sciences version 15.0 
(SPSS Inc, Chicago, IL, USA). Sensitivity, specificity, 
positive predictive value (PPV) and negative predictive 
value (NPV) of the HpOne and CLO tests were 
calculated using histology as the gold standard for the 
diagnosis of H. pylori infection.
  
RESULTS
Of the 149 patients enrolled in our study, 82 (55%) 
were men and 67 (45%) were women. The mean age 
was 44.7 (range 18–81) years. The main indication for 
gastroscopy was epigastric pain in 107 (71.8%) patients. 
The prevalence of H. pylori infection was found to be 
38.9% (n = 58). The number of positive results for the 
HpOne and CLO tests at the respective time intervals 
is presented in Table I. After 60 minutes, all positive 
HpOne test results were reflected, while only 82.3% of 
positive CLO test results were seen.
 In comparison with the histology results (Table 
II), the HpOne test had a sensitivity and specificity of 
65.5% and 85.7%, respectively, while those for the CLO 
test were 63.8% and 84.6%, respectively (Table III). 
Tables IV and V show the positive and negative results 
of each test. Although both the CLO and HpOne tests 
were more sensitive when using corpus samples, the 
highest sensitivity for both tests was obtained when both 
the findings of the body and antrum were considered 
together. As the study was not powered or designed 
to compare sampling from the body to the antrum, no 
further inference could be made with regard to which 
biopsy site is better. Our current practice is to obtain 
biopsies from both sites for each rapid urease test.
Table I. Results of positive HpOne and CLO tests at 
various time intervals.
Time interval No. of positive tests (%)
HpOne CLO
30 min 27 (52.9) 25 (49.0)
60 min 51 (100) 42 (82.3)
24 hr 51 (100) 51 (100)
Table II. The results of CLO and HpOne tests compared 
with histology.
Positive histology
(n = 58)
Negative histology
(n = 91)
CLO Test
Positive
Negative
37
21
14
77
HpOne Test
Positive
Negative
38
20
13
78
Table III. The results of CLO and HpOne tests compared 
with histology.
Sensitivity (%) Specificity (%) PPV (%) NPV (%)
HpOne 65.5 85.7 74.5 79.6
CLO test 63.8 84.6 72.5 78.6
PPV: positive predictive value; NPV: negative predictive value
Fig. 1 Flowchart shows the study design and biopsy protocol.
149 patients
Gastroscopy
Antrum Antrum Antrum
HpOne
30 min
60 min
24 hr
30 min
60 min
24 hr
30 min
60 min
24 hr
30 min
60 min
24 hr
HpOneCLO CLOHistology Histology
Body Body Body
Singapore Med J 2011; 52(11) : 816
DISCUSSION
H. pylori infection is a widespread infection, and its 
prevalence rates are influenced by age, race, geographic 
distribution and the socioeconomic status of the 
patient.(6,7) The prevalence rates in developing countries 
may be as high as 70%, in contrast to approximately 40% 
in developed countries.(8) In the current study, the local 
prevalence rate of H. pylori infection, at 38.9%, is not 
significantly different, and closely mirrors that reported 
by Fock(2) more than a decade ago. Despite reports 
of falling prevalence rates, particularly in developed 
countries, there remains considerable morbidity and 
mortality associated with H. pylori infection for 
clinicians to maintain a vested interest in its diagnosis 
and subsequent management.
 Endoscopic biopsy and rapid urease testing is the 
most simple and rapid method for identifying H. pylori 
infection during endoscopy.(9) Although the CLO test 
has been shown to be efficacious in the diagnosis of H. 
pylori,(9) it requires refrigeration for storage and warming 
to room temperature before use, and most importantly, 
has a recommended incubation period of 24 hours.(10) 
Another test that has been used in Singapore is the HpFast 
test (GI Supply, Camp Hill, PA, USA), which must be read 
after a period of 24 hours. These requirements present 
clear obstacles to efficient patient management, as the 
patient would need to present for a second consultation on 
a separate day to review the test results, thereby delaying 
the initiation of treatment.
 In this study, the authors used a defined gold 
standard of histology and compared the HpOne test with 
the CLO test, the latter usually used as the benchmark 
when validating newer rapid urease tests. It was found 
that all positive results from the HpOne test kit could 
be read within 60 minutes, with 52.9% of the positive 
results reflected within 30 minutes. The sensitivity and 
specificity of the test were not significantly different 
from those of the CLO test. Similarly, a study conducted 
by Tseng et al(5) reported that the sensitivity, specificity, 
PPV and NPV of the HpOne test were not significantly 
different from those of the CLO test.
 No true gold standard, however, exists for the 
diagnosis of H. pylori, and biopsy-based testing is usually 
used as a reference point.(10) The most commonly used 
methods are bacterial culture, histological identification 
and rapid urease testing. As such, there is a fairly wide 
range in the sensitivity and specificity values of H. pylori 
diagnostic tests reported in the literature, depending 
on what was used as the ‘gold standard’ in the study 
design. The CLO test has a sensitivity and specificity of 
56.6%–97.4% and 93.5%–100%, respectively.(5,10-12) The 
sensitivity and specificity of our CLO test is well within 
the abovementioned reported ranges.
 Up till 2009, four out of five of the teaching hospitals 
in Singapore were still using rapid urease tests that had to 
be read at 24 hours (either CLO or HpFast tests). Using 
such tests creates problems in the workflow with regard 
to patient reviews after gastroscopy, and may result in an 
unnecessary delay in the treatment of H. pylori. There 
is also the possibility that some positive results may be 
missed if the test is read too early or if it is not read at the 
24-hour mark. As a validated and faster test kit that has 
been shown to be comparable to the widely used CLO 
test, the HpOne test presents itself as a viable alternative. 
Table IV. HpOne test results in comparison with histology.
Antral Body Both/either
antral or body
Both antral
and body
HpOne
positive
HpOne
negative
HpOne
positive
HpOne
negative
HpOne
positive
HpOne
negative
Histology positive (n = 58) 35 23 38 20 38 20
Histology negative (n = 91) 13 78 12 79 13 78
Table V. CLO test results in comparison with histology.
Antral Body Both/either
antral or body
Both antral
and body
CLO
positive
CLO
negative
CLO
positive
CLO
negative
CLO
positive
CLO
negative
Histology positive (n = 58) 34 24 37 21 37 21
Histology negative (n = 91) 11 80 14 77 14 77
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A test that could be read sooner would address the 
systemic problems in the workflow in terms of reading 
the rapid urease test. Furthermore, it is less expensive 
than the CLO test. The fact that positive results can be 
interpreted within the hour would overcome the logistical 
issues discussed above. The patient can potentially have 
a doctor review the results of the test on the same day as 
his gastroscopy appointment, leading to reduced patient 
expenses, time saved by both parties and more efficient 
patient management on the whole. Of note is the fact 
that despite both the HpOne and HpFast test kits being 
available from the same company in Singapore, some 
hospitals continue to use the latter. Thus, it is important 
that the results of this study be presented, as HpOne is 
a rapid urease test that is not only highly accurate but 
capable of yielding faster reading.
 In conclusion, our study shows that the HpOne test 
is as efficacious as the CLO test in the diagnosis of H. 
pylori infection from gastroscopy biopsy specimens. The 
authors believe that HpOne is a reliable, affordable and 
highly attractive rapid urease test that clinicians can use 
for the rapid diagnosis of H. pylori infection.
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